Literature DB >> 32970831

Association of variants in PTPN22, CTLA-4, IL2-RA, and INS genes with type 1 diabetes in Emiratis.

Charu Sharma1, Bassam R Ali2,3, Wael Osman4, Bachar Afandi5, Elhadi H Aburawi6, Salem A Beshyah7, Zeina Al-Mahayri3, Rami H Al-Rifai8, Zain Al Yafei9, Gehad ElGhazali9, Juma Alkaabi1.   

Abstract

Type 1 diabetes (T1D) is a chronic autoimmune disease with a complex interrelation of genetic and environmental factors. Genetic studies have reported HLA and non-HLA loci as significant contributors to T1D. However, the genetic basis of T1D among Emiratis is unexplored. This study aims to determine the contribution of four genes PTPN22, CTLA-4, IL2-RA, and INS to T1D risk among Emiratis. The association between variants in PTPN22 (rs2476601, rs1310182), CTLA-4 (rs11571316, rs231775, rs3087243, rs1427676, and rs231727), IL2-RA (rs7090530), and INS (rs7111341) with T1D was tested in 310 Emiratis (139 T1D patients and 171 controls). A significant association was found at rs1310182, and rs2476601 both in PTPN22, rs3087243, and rs231775 both in CTLA-4, and rs12251307 in IL2-RA. Moreover, a haplotype constituted from GG and AG genotypes at rs231727 and rs231775, respectively, in CTLA-4 was significantly associated with an increased T1D risk. The cumulative effects of risk alleles for all significantly associated SNPs showed 11.8 higher relative risk for T1D for those who carry 5-6 compared to 0-1 risk alleles. This study illustrated that PTPN22, CTLA-4, and IL2-RA gene variants could confer risk alleles for T1D among the Emirati population.
© 2020 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  CTLA-4; Emirati; IL2-RA; INS; PTPN22; genetic polymorphism; type 1 diabetes

Mesh:

Substances:

Year:  2020        PMID: 32970831     DOI: 10.1111/ahg.12406

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  3 in total

1.  Class I MHC Polymorphisms Associated with Type 2 Diabetes in the Mexican Population.

Authors:  Paola Mendoza-Ramírez; Mildred Alejandra López-Olaiz; Adriana Lizeth Morales-Fernández; María Isabel Flores-Echiveste; Antonio de Jesus Casillas-Navarro; Marco Andrés Pérez-Rodríguez; Felipe de Jesús Orozco-Luna; Celso Cortés-Romero; Laura Yareni Zuñiga; María Guadalupe Sanchez Parada; Luis Daniel Hernandez-Ortega; Arieh Roldán Mercado-Sesma; Raúl C Baptista-Rosas
Journal:  Genes (Basel)       Date:  2022-04-27       Impact factor: 4.141

2.  Genetics: Is LADA just late onset type 1 diabetes?

Authors:  M Hernández; Y Nóvoa-Medina; R Faner; E Palou; A Esquerda; E Castelblanco; A M Wägner; D Mauricio
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-10       Impact factor: 6.055

3.  Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes.

Authors:  Raya Almazrouei; Charu Sharma; Bachar Afandi; Khaled M Aldahmani; Elhadi H Aburawi; Salem A Beshyah; Gehad ElGhazali; Zain Al Yafei; Rami H Al-Rifai; Juma Alkaabi
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.